Atomic Launches to Bridge the Gap Between Breakthrough MedTech Innovation and Venture-Ready Business

13 November 2025 | Thursday | News

Created by Goodwin, Three Bridges, and Match Health Collective, the new service offers a first-of-its-kind, zero-equity model that integrates legal, financial, and strategic expertise to help founders become VC ready.

-Atomic launches today as a first-of-its-kind service offering for MedTech startups built to bridge the gap between breakthrough concepts and investor-ready ventures.

Built by three industry leaders, Goodwin (legal), Three Bridges (business and financial), and Match Health Collective (strategic marketing and design) - Atomic provides a fully integrated suite of legal, financial, and strategic services that equip founders with everything they need to become VC ready.

In a rapidly evolving investment landscape, early-stage MedTech founders face growing pressure to demonstrate market readiness before securing funding from institutional VC investors. With investors waiting longer and expecting stronger legal, financial, and strategic foundations, raising capital has never been more challenging.

Unlike traditional accelerators or advisory firms, Atomic offers a fixed fee, zero-equity model that provides founders with tangible deliverables, from IP strategy and financial models to investor decks and branding. Designed for a select number of high-potential companies, Atomic gives founders the depth of guidance and expert alignment needed to accelerate toward market leadership. This model reflects Atomic’s long-term partnership philosophy: by offering these integrated services at a lower upfront cost, it aims to help promising founders reach funding milestones faster and continue supporting them as they scale.

“After supporting countless VC financings over the years, the biggest challenge we see for MedTech companies that come to us is the significant gap between innovative technology and a real fundable business,” said Marty Gomez, partner at Goodwin and Co-Founder of Atomic. “By aligning legal, financial, and market strategy from the outset, we help a select group of founders show up ready for investors and positioned to lead the next generation of MedTech innovation.”

The first company to complete the Atomic program, Contrario Medical raised $2.3M in seed funding within five weeks, establishing a strong foundation for rapid growth.

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close